Royal College of Surgeons in Ireland

MolecuLight Fluorescence Imaging Demonstrates Superior Outcomes in Deep Sternal Wound Infections, Reducing Costs and Complications

- A Taiwan study published in the Journal of Wound Care shows MolecuLight's real-time fluorescence imaging significantly improves infection control in deep sternal wound infections, with 26-fold higher likelihood of normalized white blood cell counts within 7 days. - The technology reduced antibiotic use duration from 29.5 to 22 days and cut antibiotic costs by nearly two-thirds, while patients experienced 70% shorter ICU stays and 20% faster complete wound healing. - MolecuLight imaging was associated with 82% lower risk of in-hospital wound reinfection and 86% lower risk of recurrent osteomyelitis compared to standard hyperbaric oxygen therapy. - A systematic review by Trinity College Dublin researchers analyzing 17 studies confirms MolecuLight's clinical utility, with the technology leading clinicians to change treatment plans 68.9% of the time.